Anavex Life Sciences Corp (AVXL)

[hnbadger1]

https://medium.com/parkinsons-uk/whats-going-on-with-research-into-parkinson-s-390b446f0559?source=collection_home---4------0-----------------------

“ Are there any particular areas of research or clinical trials on the Hope List that you are excited about?
1. ANAVEX 2–73 for thinking and memory problems in Parkinson’s
March 2022 saw the publication of results from a phase 2 trial looking at whether a drug called ANAVEX 2–73 could improve cognitive symptoms in Parkinson’s. After 14 weeks of treatment they found a significant improvement in thinking and memory assessments as well as other motor and non-motor symptoms. This is very promising considering this is a relatively short treatment period. We are awaiting news of a phase 3 trial to further investigate these benefits in a larger number of people.”